Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Saved in:
| Title: | Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium. |
|---|---|
| Authors: | Jacobs MT; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Jain MD; Moffitt Cancer Center, Tampa, FL., Gao F; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX., Spiegel JY; Stanford University Medical Center, Stanford, CA., Lin Y; Mayo Clinic, Rochester, MN., Dahiya S; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD., Lunning M; University of Nebraska Medical Center, Omaha, NE., Lekakis L; University of Miami Miller School of Medicine, Miami, FL., Reagan PM; University of Rochester Medical Center, Rochester, NY., Oluwole OO; Vanderbilt-Ingram Cancer Center, Nashville, TN., McGuirk J; University of Kansas Medical Center, Kansas City, KS., Deol A; Karmanos Center Institute/Wayne State University, Detroit, MI., Sehgal A; UPMC Hillman Cancer Center, Pittsburgh, PA., Goy A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ., Hill BT; Cleveland Clinic, Cleveland, OH., Andreadis C; University of CA San Francisco, San Francisco, CA., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ., Chavez JC; Dept. of Malignant Hematology, Moffitt Cancer Center, Washington, DC., Bennani NN; Mayo Clinic, Rochester, MN., Rapoport AP; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD., Vose JM; University of Nebraska Medical Center, Omaha, NE., Miklos DB; Stanford University Medical Center, Stanford, CA., Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX., Ghobadi A; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Locke FL; Moffitt Cancer Center, Tampa, FL. Electronic address: Frederick.Locke@moffitt.org. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 (10), pp. 753-759. Date of Electronic Publication: 2022 May 23. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35780055 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jacobs+MT%22">Jacobs MT</searchLink>; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO.<br /><searchLink fieldCode="AU" term="%22Jain+MD%22">Jain MD</searchLink>; Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Gao+F%22">Gao F</searchLink>; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO.<br /><searchLink fieldCode="AU" term="%22Nastoupil+LJ%22">Nastoupil LJ</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Spiegel+JY%22">Spiegel JY</searchLink>; Stanford University Medical Center, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Dahiya+S%22">Dahiya S</searchLink>; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Lunning+M%22">Lunning M</searchLink>; University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Lekakis+L%22">Lekakis L</searchLink>; University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Reagan+PM%22">Reagan PM</searchLink>; University of Rochester Medical Center, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Oluwole+OO%22">Oluwole OO</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22McGuirk+J%22">McGuirk J</searchLink>; University of Kansas Medical Center, Kansas City, KS.<br /><searchLink fieldCode="AU" term="%22Deol+A%22">Deol A</searchLink>; Karmanos Center Institute/Wayne State University, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Sehgal+A%22">Sehgal A</searchLink>; UPMC Hillman Cancer Center, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Goy+A%22">Goy A</searchLink>; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Cleveland Clinic, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Andreadis+C%22">Andreadis C</searchLink>; University of CA San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Munoz+J%22">Munoz J</searchLink>; Banner MD Anderson Cancer Center, Gilbert, AZ.<br /><searchLink fieldCode="AU" term="%22Chavez+JC%22">Chavez JC</searchLink>; Dept. of Malignant Hematology, Moffitt Cancer Center, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Bennani+NN%22">Bennani NN</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Rapoport+AP%22">Rapoport AP</searchLink>; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Vose+JM%22">Vose JM</searchLink>; University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Stanford University Medical Center, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Neelapu+SS%22">Neelapu SS</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Ghobadi+A%22">Ghobadi A</searchLink>; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Moffitt Cancer Center, Tampa, FL. Electronic address: Frederick.Locke@moffitt.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 (10), pp. 753-759. <i>Date of Electronic Publication: </i>2022 May 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35780055 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2022.05.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 753 Titles: – TitleFull: Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jacobs MT – PersonEntity: Name: NameFull: Jain MD – PersonEntity: Name: NameFull: Gao F – PersonEntity: Name: NameFull: Nastoupil LJ – PersonEntity: Name: NameFull: Spiegel JY – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Dahiya S – PersonEntity: Name: NameFull: Lunning M – PersonEntity: Name: NameFull: Lekakis L – PersonEntity: Name: NameFull: Reagan PM – PersonEntity: Name: NameFull: Oluwole OO – PersonEntity: Name: NameFull: McGuirk J – PersonEntity: Name: NameFull: Deol A – PersonEntity: Name: NameFull: Sehgal A – PersonEntity: Name: NameFull: Goy A – PersonEntity: Name: NameFull: Hill BT – PersonEntity: Name: NameFull: Andreadis C – PersonEntity: Name: NameFull: Munoz J – PersonEntity: Name: NameFull: Chavez JC – PersonEntity: Name: NameFull: Bennani NN – PersonEntity: Name: NameFull: Rapoport AP – PersonEntity: Name: NameFull: Vose JM – PersonEntity: Name: NameFull: Miklos DB – PersonEntity: Name: NameFull: Neelapu SS – PersonEntity: Name: NameFull: Ghobadi A – PersonEntity: Name: NameFull: Locke FL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2022 Oct Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 22 – Type: issue Value: 10 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
